Effects of baroreflex activation therapy on arterial stiffness and central hemodynamics in patientswith resistant hypertension

Journal of Hypertension

Volumn 33, Issue 1, 2015, Pages 181-186

  Wallbach, M ^a   Lehnig, Luca Yves ^a   Schroer, Charlotte ^b   Helms, Hans Joachim ^a   Lüders, Stephan ^c   Patschan, Daniel ^a   Patschan, Susann ^a   Müller, Gerhard A ^a   Wachter, Rolf ^b   Koziolek, Michael J ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b Department of Cardiology and Pneumology ^*  (United States)

^c ST JOSEFS HOSPITAL   (Germany)

Author keywords

Arterial stiffness; Baroreflex activation therapy; Pulse wave velocity; Resistant hypertension

Indexed keywords

AORTA; ARTERIAL STIFFNESS; BLOOD; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DRUG EFFECTS; FEMALE; HEART RATE; HEMODYNAMICS; HUMAN; HYPERTENSION; MALE; MANOMETRY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PRESSORECEPTOR REFLEX; PROCEDURES; PROSPECTIVE STUDY; PULSE WAVE; RADIAL ARTERY; RISK FACTOR; TIME;

AORTA; BAROREFLEX; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; CARDIOVASCULAR DISEASES; FEMALE; HEART RATE; HEMODYNAMICS; HUMANS; HYPERTENSION; MALE; MANOMETRY; MIDDLE AGED; PROSPECTIVE STUDIES; PULSE WAVE ANALYSIS; RADIAL ARTERY; RISK FACTORS; TIME FACTORS; VASCULAR STIFFNESS;

EID: 84916930489     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000361     Document Type: Article

References (31)

1. Chirinos JA, Kips JG, Jacobs DR Jr, Brumback L, Duprez DA, Kronmal R, et al. Arterial wave reflections and incident cardiovascular events and heart failure: MESA (Multiethnic Study of Atherosclerosis). J Am Coll Cardiol 2012; 60: 2170-2177.
2. Pabuccu T, Baris N, Ozpelit E, Akdeniz B, Guneri S. The relationship between resistant hypertension and arterial stiffness. Clin Exp Hypertens 2012; 34: 57-62.
3. Nichols WW, Edwards DG. Arterial elastance and wave reflection augmentation of systolic blood pressure: Deleterious effects and implications for therapy. J Cardiovasc Pharmacol Ther 2001; 6: 5-21.
4. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al., ESH-ESC Task Force on the Management of Arterial Hypertension. 2007 ESH-ESC practice guidelines for the management of arterial hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens 2007; 25: 1751-1762.
5. ESH/ESC Task Force for the Management of Arterial Hypertension. 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. J Hypertens 2013; 31: 1925-1938.
6. Virdis A, Ghiadoni L, Qasem AA, Lorenzini G, Duranti E, Cartoni G, et al. Effect of aliskiren treatment on endothelium-dependent vasodilation and aortic stiffness in essential hypertensive patients. Eur Heart J 2012; 33: 1530-1538.
7. Ong KT, Delerme S, Pannier B, Safar ME, Benetos A, Laurent S, Boutouyrie P, investigators. Aortic stiffness is reduced beyond blood pressure lowering by short-Term and long-Term antihypertensive treatment: A meta-Analysis of individual data in 294 patients. J Hypertens 2011; 29: 1034-1042.
8. Hoppe UC, Brandt MC, Wachter R, Beige J, Rump LC, Kroon AA, et al. Minimally invasive system for baroreflex activation therapy chronically lowers blood pressure with pacemaker-like safety profile: Results from the Barostim neo trial. J Am Soc Hypertens 2012; 6: 270-276.
9. Bisognano JD, Bakris G, Nadim MK, Sanchez L, Kroon AA, Schafer J, et al. Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: Results from the double-blind, randomized, placebo-controlled rheos pivotal trial. J Am Coll Cardiol 2011; 58: 765-773.
10. Palatini P, Casiglia E, Gasowski J, Gluszek J, Jankowski P, Narkiewicz K, et al. Arterial stiffness, central hemodynamics, and cardiovascular risk in hypertension. Vasc Health Risk Manag 2011; 7: 725-739.
11. Brandt MC, Reda S, Mahfoud F, Lenski M, Böhm M, Hoppe UC. Effects of renal sympathetic denervation on arterial stiffness and central hemodynamics in patients with resistant hypertension. J Am Coll Cardiol 2012; 60: 1956-1965.
12. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al., Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood, Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-1252.
13. Radhakrishnan J, Cattran DC. The KDIGO practice guideline on glomerulonephritis: Reading between the (guide)lines-Application to the individual patient. Kidney Int 2012; 82: 840-856.
14. Kidney Disease Outcomes Quality Initiative (K/DOQI). K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis 2004; 43 (Suppl 1): 1-290.
15. KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group. Kidney Int Suppl 2012; 2: 337-414.
16. Tordoir JH, Scheffers I, Schmidli J, Savolainen H, Liebeskind U, Hansky B, et al. An implantable carotid sinus baroreflex activating system: Surgical technique and short-Term outcome from a multicenter feasibility trial for the treatment of resistant hypertension. Eur J Vasc Endovasc Surg 2007; 33: 414-421.
17. Van Bortel LM, Laurent S, Boutouyrie P, Chowienczyk P, Cruickshank JK, De Backer T, et al., Artery Society; European Society of Hypertension Working Group on Vascular Structure and Function; European Network for Noninvasive Investigation of Large Arteries. Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens 2012; 30: 445-448.
18. Siebenhofer A, Kemp C, Sutton A, Williams B. The reproducibility of central aortic blood pressure measurements in healthy subjects using applanation tonometry and sphygmocardiography. J Hum Hypertens 1999; 13: 625-629.
19. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: Establishing normal and reference values'. Eur Heart J 2010; 31: 2338-2350.
20. Pauca AL, O'Rourke MF, Kon ND. Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform. Hypertension 2001; 38: 932-937.
21. Gedikli O, Kiris A, Ozturk S, Baltaci D, Karaman K, Durmus I, et al. Effects of prehypertension on arterial stiffness and wave reflections. Clin Exp Hypertens 2010; 32: 84-89.
22. Chemla D, Nitenberg A, Teboul JL, Richard C, Monnet X, le Clesiau H, et al. Subendocardial viability index is related to the diastolic/systolic time ratio and left ventricular filling pressure, not to aortic pressure: An invasive study in resting humans. Clin Exp Pharmacol Physiol 2009; 36: 413-418.
23. Tomlinson LA. Methods for assessing arterial stiffness: Technical considerations. Curr Opin Nephrol Hypertens 2012; 21: 655-660.
24. Henry RM, Kostense PJ, Spijkerman AM, Dekker JM, Nijpels G, Heine RJ, et al. Arterial stiffness increases with deteriorating glucose tolerance status: The Hoorn Study. Circulation 2003; 107: 2089-2095.
25. Bakris GL, Nadim MK, Haller H, Lovett EG, Schafer JE, Bisognano JD. Baroreflex activation therapy provides durable benefit in patients with resistant hypertension: Results of long-Term follow-up in the Rheos Pivotal Trial. J Am Soc Hypertens 2012; 6: 152-158.
26. Bhatt DL, Kandzari DE, O'Neill WW, D'Agostino R, Flack JM, Katzen BT, et al. A controlled trial of renal denervation for resistant hypertension. N Engl J Med 2014; 10: 1393-1401.
27. Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, Collier D, et al., CAFE Investigators; Anglo-Scandinavian Cardiac Outcomes Trial Investigators; CAFE Steering Committee and Writing Committee. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: Principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 2006; 113: 1213-1225.
28. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, et al., European Network for Noninvasive Investigation of Large Arteries. Expert consensus document on arterial stiffness: Methodological issues and clinical applications. Eur Heart J 2006; 27: 2588-2605.
29. Ben-Shlomo Y, Spears M, Boustred C, May M, Anderson SG, Benjamin EJ, et al. Aortic pulse wave velocity improves cardiovascular event prediction: An individual participant meta-Analysis of prospective observational data from 17, 635 subjects. J Am Coll Cardiol 2014; 63: 636-646.
30. Steppan J, Barodka V, Berkowitz DE, Nyhan D. Vascular stiffness and increased pulse pressure in the aging cardiovascular system. Cardiol Res Pract 2011; 2011: 263585.
31. Quinn U, Tomlinson LA, Cockcroft JR. Arterial stiffness. JRSM Cardiovasc Dis 2012; 1 (6).